We showed that amplifications of cell cycle-related genes such as CCND1 and CDK4/6 and deletion of CDKN2A gene co-exist in considerable proportions of EGFR-amplified ESCC. The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.